FDA has approved Daytrana, a once-daily skin patch for treating attention deficit hyperactivity disorder (ADHD) in children aged 6 to 12 years. FDA calls the patch "an alternate route of administration" for the drug treatment. ADHD affects about three to seven percent of school-aged children in this country. http://www.fda.gov/bbs/topics/NEWS/2006/NEW01352.html Powered by LSoft's LISTSERV(R) list management software